LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of …

J Bourhis, C Sire, Y Tao, L Martin, M Alfonsi… - Annals of …, 2020 - annalsofoncology.org
Background Based on the hypothesis of a potential synergistic effect of the anti-PD1
pembrolizumab when combined with RT, this new combination was tested in a randomized …
被引用次数：70 相关文章

[引用][C] Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of …

J Bourhis, C Sire, Y Tao, L Martin, M Alfonsi… - Annals of …, 2020 - u-picardie.hal.science
Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced
head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 ``PembroRad'' …

[引用][C] Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of …

J Bourhis, C Sire, Y Tao, L Martin, M Alfonsi… - Annals of …, 2020 - hal.science
Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced
head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 ``PembroRad'' …